摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,6S)-6,7-二甲氧基-2,2,4-三甲基-4,6,7,7a-四氢-3aH-[1,3]二噁唑并[4,5-c]吡喃 | 769067-34-7

中文名称
(3aS,6S)-6,7-二甲氧基-2,2,4-三甲基-4,6,7,7a-四氢-3aH-[1,3]二噁唑并[4,5-c]吡喃
中文别名
——
英文名称
2-Deoxystreptamin
英文别名
4,6-Diaminocyclohexane-1,2,3-triol
(3aS,6S)-6,7-二甲氧基-2,2,4-三甲基-4,6,7,7a-四氢-3aH-[1,3]二噁唑并[4,5-c]吡喃化学式
CAS
769067-34-7
化学式
C6H14N2O3
mdl
——
分子量
162.189
InChiKey
DTFAJAKTSMLKAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3.2
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    113
  • 氢给体数:
    5
  • 氢受体数:
    5

文献信息

  • NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC FOR MULTIDRUG-RESISTANT BACTERIA
    申请人:Microbial Chemistry Research Foundation
    公开号:EP3498723A1
    公开(公告)日:2019-06-19
    A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.
    本发明公开了一种由以下通式(I)代表的化合物或其药学上可接受的盐或溶液及其药物组合物,以及用其预防或治疗传染性疾病的方法和使用这些方案预防或治疗传染性疾病的方法。式(I)代表的化合物对革兰氏阳性菌和革兰氏阴性菌都具有抗菌活性,可用于预防或治疗由这些细菌引起的传染性疾病。
  • Molecules which Bind to the Dimerization Initiation Site (DIS) of HIV RNA, Their Synthesis and Their Applications as Drugs
    申请人:Pale Patrick
    公开号:US20110118202A1
    公开(公告)日:2011-05-19
    The dimerization of HIV RNA is a key step in the virus replication cycle. Based on RNA DIS crystal structures, a novel kind of compounds, dimeric or not, based on neamine was designed and synthesized. Biological studies showed that such compounds bind and interfere with the targeted RNA sequence, opening a new anti-HIV approach. The crystal structures and bio-chemical experiments showed that the DIS of HIV-1 genomic RNA is a target for new anti-HIV drugs and that those drugs could be derived from aminoglycosides. The results revealed that binding of aminoglycosides to the DIS is specific regarding both the aminoglycoside family and the RNA subtype.
  • MODULAR SYNTHESIS OF AMINOGLYCOSIDES
    申请人:REVAGENIX, INC.
    公开号:US20220411456A1
    公开(公告)日:2022-12-29
    The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds and the compounds used in such preparations.
  • US4340715A
    申请人:——
    公开号:US4340715A
    公开(公告)日:1982-07-20
  • US4366302A
    申请人:——
    公开号:US4366302A
    公开(公告)日:1982-12-28
查看更多